Cargando…

Comparison of different conditions for DNA extraction in sputum - a pilot study

BACKGROUND: The analysis of microbiome in respiratory samples is a topic of great interest in chronic respiratory diseases. The method used to prepare sputum samples for microbiome analysis is very heterogeneous. The selection of the most suitable methodology for DNA extraction is fundamental to hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oriano, Martina, Terranova, Leonardo, Teri, Antonio, Sottotetti, Samantha, Ruggiero, Luca, Tafuro, Camilla, Marchisio, Paola, Gramegna, Andrea, Amati, Francesco, Nava, Fabrizio, Franceschi, Elisa, Cariani, Lisa, Blasi, Francesco, Aliberti, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357456/ https://www.ncbi.nlm.nih.gov/pubmed/30733864 http://dx.doi.org/10.1186/s40248-018-0166-z

Ejemplares similares

How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis
por: Terranova, Leonardo, et al.
Publicado: (2018)

Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients
por: Terranova, Leonardo, et al.
Publicado: (2022)

Protease–Antiprotease Imbalance in Bronchiectasis
por: Oriano, Martina, et al.
Publicado: (2021)

When and how ruling out cystic fibrosis in adult patients with bronchiectasis
por: Gramegna, Andrea, et al.
Publicado: (2018)

The Isoform GC1f of the Vitamin D Binding Protein Is Associated with Bronchiectasis Severity
por: Oriano, Martina, et al.
Publicado: (2021)

Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients
por: Aliberti, Stefano, et al.
Publicado: (2022)

Neutrophil elastase in bronchiectasis
por: Gramegna, Andrea, et al.
Publicado: (2017)

The biology of pulmonary exacerbations in bronchiectasis
por: Amati, Francesco, et al.
Publicado: (2019)

T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis
por: Oriano, Martina, et al.
Publicado: (2021)

Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience
por: Amati, Francesco, et al.
Publicado: (2022)

SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity
por: Blasi, Francesco, et al.
Publicado: (2021)

Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review
por: Amati, Francesco, et al.
Publicado: (2023)

In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm
por: Pollini, Simona, et al.
Publicado: (2018)

Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2023)

Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia
por: Amati, Francesco, et al.
Publicado: (2023)

From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2020)

Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review
por: Gramegna, Andrea, et al.
Publicado: (2022)

Prevalence and incidence of bronchiectasis in Italy
por: Aliberti, Stefano, et al.
Publicado: (2020)

Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis
por: Suska, Kseniia, et al.
Publicado: (2022)

Walking the path of treatable traits in interstitial lung diseases
por: Amati, Francesco, et al.
Publicado: (2023)

Upper Respiratory Tract Microbiome and Otitis Media Intertalk: Lessons from the Literature
por: Folino, Francesco, et al.
Publicado: (2020)

Prognostic parameters of in‐hospital mortality in COVID‐19 patients—An Italian experience
por: Ruscica, Massimiliano, et al.
Publicado: (2021)

Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement
por: Gramegna, Andrea, et al.
Publicado: (2018)

In Vitro Synergism of Colistin and N-acetylcysteine against Stenotrophomonas maltophilia
por: Ciacci, Nagaia, et al.
Publicado: (2019)

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
por: Amati, Francesco, et al.
Publicado: (2022)

Idiopathic interstitial pneumonia in a patient with von Hippel–Lindau syndrome: a first case
por: Morlacchi, Letizia Corinna, et al.
Publicado: (2023)

Lung Recruitability of COVID-19 Pneumonia in Patients Undergoing Helmet CPAP
por: Amati, Francesco, et al.
Publicado: (2021)

Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis
por: Sotgiu, Giovanni, et al.
Publicado: (2018)

Evolving serodiagnostics by rationally designed peptide arrays: the Burkholderia paradigm in Cystic Fibrosis
por: Peri, Claudio, et al.
Publicado: (2016)

SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

Clinical applications of azithromycin microspheres in respiratory tract infections
por: Blasi, Francesco, et al.
Publicado: (2007)

COVID-19 multidisciplinary high dependency unit: the Milan model
por: Aliberti, Stefano, et al.
Publicado: (2020)

Incidental occurrence of neutropenia in children hospitalised for COVID-19
por: Folino, Francesco, et al.
Publicado: (2022)

Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Alicandro, G., et al.
Publicado: (2023)

Cardiovascular Complications in Community-Acquired Pneumonia
por: Desai, Antonio, et al.
Publicado: (2022)

Predictors of Helmet CPAP Failure in COVID-19 Pneumonia: A Prospective, Multicenter, and Observational Cohort Study
por: Santus, Pierachille, et al.
Publicado: (2022)

Mixed community-acquired lower respiratory tract infections
por: Tarsia, Paolo, et al.
Publicado: (2007)

Response
por: Retucci, Mariangela, et al.
Publicado: (2021)

Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis
por: Contarini, Martina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pmcf22je5il8in72q2g5h8jifm